Methyltestosterone
Back to searchMolecule Structure
Scientific Name
Methyltestosterone
Description of the Drug
Methyltestosterone is a synthetic anabolic steroid used for the replacement therapy in conditions associated with testosterone deficiencies in males, such as hypogonadism, and treatment of advancing inoperable metastatic breast cancer in females.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06710
http://www.drugbank.ca/drugs/DB06710
Brand Name(s)
Android 10, Android 25, Android 5, Metandren, Methitest, Methyltestosterone, Oreton, Oreton methyl, Perandren, Plex hormone, Potensan fte, Testovis, Testred, Virilon
Company Owner(s)
Schering Corp Sub Schering Plough Corp, Chartwell Star Rx Llc, Kv Pharmaceutical Co, Watson Laboratories Inc, Purepac Pharmaceutical Co, Novartis Pharmaceuticals Corp, Impax Laboratories Inc, Novitium Pharma Llc, Eli Lilly And Co, West Ward Pharmaceutical Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Androgen Receptor | SINGLE PROTEIN | AGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
| Atlas | methyltestosterone | ||
| SureChEMBL | SCHEMBL18657 | ||
| Human Metabolome Database | HMDB0015655 | ||
| DrugBank | DB06710 | ||
| PubChem: Thomson Pharma | 14800583 | 14776222 | |
| PubChem | 6010 | ||
| Mcule | MCULE-5274452426 | ||
| LINCS | LSM-5902 | ||
| Nikkaji | J1.385D | ||
| BindingDB | 50410531 | ||
| EPA CompTox Dashboard | DTXSID1033664 | ||
| LipidMaps | LMST02020029 | ||
| DrugCentral | 3356 | ||
| Brenda | 55876 | 29309 | |
| ChemicalBook | CB4213510 | ||
| Guide to Pharmacology | 6945 | ||
| rxnorm | METHYLTESTOSTERONE | METHITEST | TESTRED |
| KEGG Ligand | C07198 | ||
| ChEBI | 27436 | ||
| ZINC | ZINC000003814422 |
